S&P 500   4,589.39 (+1.69%)
DOW   34,728.24 (+2.08%)
QQQ   389.80 (+0.69%)
AAPL   163.55 (-0.74%)
MSFT   330.28 (+0.06%)
FB   309.34 (-0.41%)
GOOGL   2,861.57 (+1.44%)
AMZN   3,439.90 (-0.11%)
TSLA   1,078.27 (-1.53%)
NVDA   322.18 (+2.49%)
BABA   120.87 (-1.32%)
NIO   35.58 (-7.13%)
CGC   10.09 (+1.51%)
AMD   150.41 (+0.87%)
GE   95.48 (+2.67%)
MU   82.56 (-3.04%)
T   23.24 (+4.54%)
F   19.88 (+1.53%)
DIS   146.40 (+2.99%)
PFE   53.61 (-1.96%)
AMC   30.07 (+5.25%)
ACB   5.97 (-0.67%)
BA   199.61 (+6.07%)
S&P 500   4,589.39 (+1.69%)
DOW   34,728.24 (+2.08%)
QQQ   389.80 (+0.69%)
AAPL   163.55 (-0.74%)
MSFT   330.28 (+0.06%)
FB   309.34 (-0.41%)
GOOGL   2,861.57 (+1.44%)
AMZN   3,439.90 (-0.11%)
TSLA   1,078.27 (-1.53%)
NVDA   322.18 (+2.49%)
BABA   120.87 (-1.32%)
NIO   35.58 (-7.13%)
CGC   10.09 (+1.51%)
AMD   150.41 (+0.87%)
GE   95.48 (+2.67%)
MU   82.56 (-3.04%)
T   23.24 (+4.54%)
F   19.88 (+1.53%)
DIS   146.40 (+2.99%)
PFE   53.61 (-1.96%)
AMC   30.07 (+5.25%)
ACB   5.97 (-0.67%)
BA   199.61 (+6.07%)
S&P 500   4,589.39 (+1.69%)
DOW   34,728.24 (+2.08%)
QQQ   389.80 (+0.69%)
AAPL   163.55 (-0.74%)
MSFT   330.28 (+0.06%)
FB   309.34 (-0.41%)
GOOGL   2,861.57 (+1.44%)
AMZN   3,439.90 (-0.11%)
TSLA   1,078.27 (-1.53%)
NVDA   322.18 (+2.49%)
BABA   120.87 (-1.32%)
NIO   35.58 (-7.13%)
CGC   10.09 (+1.51%)
AMD   150.41 (+0.87%)
GE   95.48 (+2.67%)
MU   82.56 (-3.04%)
T   23.24 (+4.54%)
F   19.88 (+1.53%)
DIS   146.40 (+2.99%)
PFE   53.61 (-1.96%)
AMC   30.07 (+5.25%)
ACB   5.97 (-0.67%)
BA   199.61 (+6.07%)
S&P 500   4,589.39 (+1.69%)
DOW   34,728.24 (+2.08%)
QQQ   389.80 (+0.69%)
AAPL   163.55 (-0.74%)
MSFT   330.28 (+0.06%)
FB   309.34 (-0.41%)
GOOGL   2,861.57 (+1.44%)
AMZN   3,439.90 (-0.11%)
TSLA   1,078.27 (-1.53%)
NVDA   322.18 (+2.49%)
BABA   120.87 (-1.32%)
NIO   35.58 (-7.13%)
CGC   10.09 (+1.51%)
AMD   150.41 (+0.87%)
GE   95.48 (+2.67%)
MU   82.56 (-3.04%)
T   23.24 (+4.54%)
F   19.88 (+1.53%)
DIS   146.40 (+2.99%)
PFE   53.61 (-1.96%)
AMC   30.07 (+5.25%)
ACB   5.97 (-0.67%)
BA   199.61 (+6.07%)
FRA:SY1

Symrise Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
€112.10
€131.30
52-Week Range
N/A
Volume
421,221 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive SY1 News and Ratings via Email

Sign-up to receive the latest news and ratings for Symrise and its competitors with MarketBeat's FREE daily newsletter.


Symrise logo

About Symrise

Symrise AG develops, produces, and supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturer of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. The Flavor segment provides flavors and functional ingredients used in the production of foods, beverages, and health products. The Nutrition segments offers tailored solutions from natural raw materials for use in foods, beverages, pet foods, and aquacultures. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

Headlines

Symrise (FRA:SY1) PT Set at €137.00 by Baader Bank
December 2, 2021 |  americanbankingnews.com
Symrise (FRA:SY1) PT Set at €115.00 by JPMorgan Chase & Co.
November 30, 2021 |  americanbankingnews.com
Symrise (FRA:SY1) PT Set at €138.00 by The Goldman Sachs Group
November 17, 2021 |  americanbankingnews.com
Symrise (FRA:SY1) Given a €140.00 Price Target at UBS Group
November 10, 2021 |  americanbankingnews.com
Symrise sees 2020 sales below its long-term target
October 29, 2020 |  finance.yahoo.com
SYMRISE AG INH. O.N. (SY1.MU)
October 12, 2020 |  in.finance.yahoo.com
Symrise Ag (ETR:SY1) price about to hit new 52-week high
August 14, 2020 |  uk.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10,531
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.29 out of 5 stars

Analyst Opinion: 3.1Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Symrise (FRA:SY1) Frequently Asked Questions

Is Symrise a buy right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Symrise in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Symrise stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SY1, but not buy additional shares or sell existing shares.
View analyst ratings for Symrise
or view top-rated stocks.

What price target have analysts set for SY1?

15 analysts have issued twelve-month target prices for Symrise's shares. Their forecasts range from €96.00 to €140.00. On average, they expect Symrise's share price to reach €122.23 in the next year.
View analysts' price targets for Symrise
or view top-rated stocks among Wall Street analysts.

Who are Symrise's key executives?

Symrise's management team includes the following people:
  • Dr. Heinz-Jurgen Bertram, CEO, Pres of Scent and Care, Chairman of Exec. Board & Labour Director (Age 63, Pay $1.66M)
  • Mr. Olaf Klinger, CFO, Head of Fin., Legal & IT Department and Member of Exec. Board (Age 56, Pay $1.02M)
  • Dr. Jean-Yves Parisot, Pres of Nutrition and Flavor & Member of Exec. Board (Age 57, Pay $1.33M)
  • Dr. Jürgen Nienhaus, Corp. VP of Operations
  • Mr. Tobias Erfurth, Head of Investor Relation
  • Mr. Roberto Ascoli, Sr. VP of New Bus. Devel. - Scent & Care Division
  • Ms. Béatrice Favre-Bulle, Sr. VP of Scent & Care
  • Mr. Alain Bourdon, Managing Director of Madagascar
  • Mr. Arnaud Bellon, Sr. VP and Global Head of Botanicals & Colors - The Cosmetic Ingredients Division
  • Ms. Marie-Laure Roumiguiere, Head of Global Account Management of EAME - Cosmetic Ingredients Division

What other stocks do shareholders of Symrise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Symrise investors own include Abbott Laboratories (ABT), Everest Re Group (RE), Ambev (ABEV), Allianz (ALV), Applied Materials (AMAT), Basf (BAS), BRF (BRFS), Daimler (DAI), Givaudan (GVDNY) and iShares Nasdaq Biotechnology ETF (IBB).

What is Symrise's stock symbol?

Symrise trades on the FRA under the ticker symbol "SY1."

How many employees does Symrise have?

Symrise employs 10,531 workers across the globe.

What is Symrise's official website?

The official website for Symrise is www.symrise.com.

Where are Symrise's headquarters?

How can I contact Symrise?

Symrise's mailing address is Muehlenfeldstrasse 1, HOLZMINDEN, 37603, Germany. The company can be reached via phone at +49-5531-900.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.